Feature TC Biopharm developing gamma-delta T-cells therapies for oncology TC BioPharm (NASDAQ:TCBP) is a global leader in developing platform allogeneic gamma-delta T-cell therapies for cancer indications, with human efficacy data in acute myeloid leukemia (AML) and plans to expand into other... July 12, 2022